All data, codes and workflows are currently fully accessible in public repositories: <https://toolshed.g2.bx.psu.edu/>, <https://github.com/ARTbio/tools-artbio>, <https://artbio.github.io/Metavisitor-manual/>, <https://mississippi.snv.jussieu.fr/>, <https://dx.doi.org/10.6084/m9.figshare.3179026.v1>, <http://www.myexperiment.org/users/65016/workflows>.

Introduction {#sec001}
============

Viruses infect cells and manipulate the host machinery for their replication and transmission. Genomes of viruses show high diversity and can consist of single- or double-stranded RNA or DNA. Many types of viral replication cycles exist which may involve various cellular compartments, various DNA or RNA replication intermediates, and diverse strategies for viral RNA transcription and viral protein translation. Thus, deep-sequencing has become a powerful approach for virologists in their quest to detect and identify viruses in biological samples, even when they are present at low levels. Plants and invertebrates use RNA interference as an antiviral mechanism \[[@pone.0168397.ref001],[@pone.0168397.ref002]\]. Antiviral RNAi activity results in accumulation of viral interfering small RNAs (viRNAs), whose extent depends on several factors such as the ability of a virus to replicate in the host and to evade the host RNAi machinery. Moreover, viRNAs derived from a variety of viruses can be detected in host organisms, regardless if these viruses have positive single strand, negative single strand or double-stranded RNA genomes, or DNA genomes \[[@pone.0168397.ref002]\]. Together, these features make small RNA deep sequencing a potent approach to detect viruses regardless of their genomic specificities, and different bioinformatic tools have been developed for detection or *de novo* assembly of viral genomes.

Accordingly, viRNAs produced by the insect model *Drosophila melanogaster* in response to viral infections were sufficient to reconstruct and improve the genomic consensus sequence of the Nora virus \[[@pone.0168397.ref003]\] using the Paparazzi software \[[@pone.0168397.ref004]\] which is based on the SSAKE assembler \[[@pone.0168397.ref005]\]. In that study, Paparazzi improved the consensus sequence and the coverage of the Nora virus genome by \~20%, as compared to the previous Nora virus reference genome. SearchSmallRNA, a standalone tool with a graphical interface, used a similar approach to reconstruct viral genomes \[[@pone.0168397.ref006]\]. Importantly, both programs require known, closely related viral references for proper guidance of genome reconstructions from viRNAs, precluding the identification of more distant viral species or discovery of novel or unexpected viruses.

To circumvent the need for viral reference sequences, Velvet \[[@pone.0168397.ref007]\] *de novo* assembled contigs from plant \[[@pone.0168397.ref008]\], fruit fly and mosquito \[[@pone.0168397.ref009]\] have been aligned to NCBI sequence databases, allowing the identification of partial or complete viral genomes. Several studies improved this strategy by combining two *de novo* assemblers \[[@pone.0168397.ref010]--[@pone.0168397.ref013]\], or scaffolding virus-aligned contigs using an additional translation-guided assembly step \[[@pone.0168397.ref014]\].

Collectively, these studies allowed important progress in virus assembly and identification from deep sequencing data. However, the existing computational workflows require specialist skills for installation, execution and adaptation to specific research, making them poorly accessible to a broad user base of biologists. In some cases, the tools lack documentation or their source codes are not available.

In this context, we developed Metavisitor as an open source set of tools and preset workflows \[[@pone.0168397.ref015],[@pone.0168397.ref016]\] which allow effective implementation of the computational strategies in the Galaxy framework, with short read as well as long read sequence datasets. In addition, Metavisitor workflows can be easily adapted to suit specific needs, by adding analysis steps or replacing/modifying existing ones with the numerous tools available in the Galaxy tool sheds. Here, we report a series of use cases of Metavisitor and we show that it provides biologists and medical practitioners with an easy-to-use and adaptable software for the detection or identification of viruses from high-throughput sequence datasets.

Experimental Procedures {#sec002}
=======================

Metavisitor consists of a set of Galaxy tools ([Fig 1](#pone.0168397.g001){ref-type="fig"}) that can be combined to (i) retrieve up-to-date nucleotide as well as protein sequences of viral genomes deposited in Genbank \[[@pone.0168397.ref017]\] and index these sequences for subsequent alignments; (ii) extract sequencing reads that do not align to the host genomes, known symbionts or parasites; (iii) perform *de novo* assembly of these reads using assembly tools available in Galaxy, align the *de novo* contigs against the viral nucleotide or protein blast databases using blastn or blastx, respectively, and generate reports from blast outputs to help in known viruses diagnosis or in candidate virus discovery; (iv) use CAP3 (optional, see Use Case 3--3), blast and viral scaffolds for selected viruses to generate guided final viral sequence assemblies of blast sequence hits. Below, we group analysis steps in functional tasks i to iv and provide details on the Metavisitor tools. These tasks are linked together to build full workflows adapted to the analysis of the use cases described in the result section.

![Global view of the Metavisitor workflow.\
The workflow is organised in sub workflows (dashed line) corresponding to functional tasks as described in the manuscript. All Galaxy Tools (square boxes) are available in the main Galaxy tool shed ([<https://toolshed.g2.bx.psu.edu/>]{.ul}).](pone.0168397.g001){#pone.0168397.g001}

(i) Get reference viral sequences {#sec003}
---------------------------------

The "Get reference viral sequences" task is performed using the "Retrieve FASTA from NCBI" tool that sends a query string to the Genbank database \[[@pone.0168397.ref017]\] and retrieves the corresponding nucleotide or protein sequences. For the viral nucleotide and protein sequences referred to as "vir1", we used the tool to query Genbank (oct 2015) and retrieve viruses sequences filtered out from cellular organisms and bacteriophage sequences (see [S1 Fig](#pone.0168397.s001){ref-type="supplementary-material"}). However, users can change the tool settings by entering query strings that fit their specific needs. As retrieving vir1 from NCBI takes several hours, we allow users to skip the step by directly accessing the nucleotides or protein vir1 datasets on the Mississippi server ([http://mississippi.fr](http://mississippi.fr/)) or to download them from figshare ([<https://dx.doi.org/10.6084/m9.figshare.3179026>]{.ul}). For convenience, nucleotide and protein blast indexes of vir1 are also available in the public library of the Mississippi server,but can also be generated using the "NCBI BLAST+ makeblastdb" Galaxy tool \[[@pone.0168397.ref018]\]. Bowtie \[[@pone.0168397.ref019]\] as well as bowtie2 \[[@pone.0168397.ref020]\] indexes of the vir1 nucleotide sequences have been generated in the Mississippi Galaxy instance using the corresponding "data manager" Galaxy tools.

Finally, users can upload their own viral nucleotide and protein sequences using ftp and transfer them to a Galaxy history ([Fig 1](#pone.0168397.g001){ref-type="fig"}), where they can use the Galaxy data manager tools to produce the blast and bowtie indexes necessary for Metavisitor.

(ii) Prepare data {#sec004}
-----------------

The "Prepare data" task ([Fig 1](#pone.0168397.g001){ref-type="fig"}) processes Illumina sequencing datasets in order to optimize the subsequent *de novo* assembly of viral sequencing reads. Fastq files of sequence reads are first clipped from library adapters and converted to fasta format using our tool "Clip adapter" tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}). The clipped reads may be further converted to a fasta file of unique sequences headed by a character string that contains a unique identifier and the number of times that the sequences were found in the dataset, thus reducing the size of the dataset without loss of information. This optional treatment removes sequence duplicates and drastically reduces the workload of the next steps as well as the coverage variations after *de novo* assembly (see Use Cases 1--1 to 1--3). Clipped reads are then depleted from non-viral sequences by sequential alignments to the host genome, to other genomes from known or potential symbionts and parasites, as well as to PhiX174 genome sequences which are commonly used as internal controls in Illumina sequencing and may contaminate the datasets ([Fig 1](#pone.0168397.g001){ref-type="fig"}). The sequence reads that did not match the reference genomes are retained and returned as a fasta file that can be used subsequently by a *de novo* assembly tool. Note that these subtraction steps can be skipped when the host genome is not known or if the aim of the user is to discover endogenous viral elements \[[@pone.0168397.ref021]\].

(iii) Assembly, Blast and Parsing {#sec005}
---------------------------------

### *De novo* assembly {#sec006}

In the task "Assemble, Blast and Parse" (iii), retained RNA sequences are subjected to *de novo* assembly. For short reads (\<50 nt), we tested several rounds of *de novo* assembly by Velvet \[[@pone.0168397.ref007]\] using the Oases software package \[[@pone.0168397.ref022]\] ([Fig 1](#pone.0168397.g001){ref-type="fig"}) and k-mer lengths ranging from 15 to 35 ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}). For reads between 50 nt and 100 nt, we also used the Oases with k-mer lengths ranging from 13 to 69. Finally in Use Case 3--3, we used the Trinity assembly software which is available as a Galaxy tool and was reported to performs well with long reads \[[@pone.0168397.ref023]\]. Trinity as well as SPAdes \[[@pone.0168397.ref024]\] assembly softwares were also tested as alternate option to Oases in the Use Case 2--2 ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}), giving similar outputs. It is noteworthy that users can adapt a Metavisitor workflow using any assembly software available in the Galaxy tool shed.

### Blast {#sec007}

Next, *de novo* assembled contigs are aligned to both nucleotide and protein vir1 BLAST databases built from the viral reference sequences ([Fig 1](#pone.0168397.g001){ref-type="fig"}) using the blastn or blastx Galaxy tools \[[@pone.0168397.ref018]\]. These tools search nucleotide or protein databases using nucleotide or translated nucleotide queries, respectively \[[@pone.0168397.ref025]\]. The default parameters are adjusted in order to report only the 5 best alignments per contig (Maximum hits option is set to 5) and to generate a tabular blast output that includes the 12 standard columns plus a column containing the length of the aligned subject sequences (extended columns option, "slen" checked). Note that this additional column in the blast output is required for subsequent parsing of the blast output by the "Parse blast output and compile hits" tool.

### Parsing {#sec008}

Tabular outputs generated by blastn and blastx alignments are processed by the "Parse blast output and compile hits" tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}), which returns 4 files, namely "blast analysis, by subjects", "hits", "Blast aligned sequences" and "Blast unaligned sequences".

In the "blast analysis, by subjects" file ([S2 Fig](#pone.0168397.s002){ref-type="supplementary-material"}), the subject sequences in the viral nucleotide or protein blast databases that produced significant blast alignments (hits) with *de novo* assembled contigs are listed, together with those contigs and hit information (% Identity, Alignment Length, start and end coordinates of hits relatively to the subject sequence, percentage of the contig length covered by the hit, E-value and Bit Score of the hit). In addition, for each subject sequence in the list, the length in nucleotide or amino-acid of the subject sequence (Subject Length), the summed coverage of the subject by all contig hits (Total Subject Coverage) as well as the fraction of the subject length that this coverage represents (Relative Subject Coverage), and the best (Best Bit Score) and mean (Mean Bit Score) bit scores produced by contig hits are computed and indicated. A simplified output can be generated without contigs and blast information by using the "compact" option for the reporting mode of the "Parse blast output and compile hits" tool. Note that the total and relative subject coverages indicate how much of the virus sequence is covered by the reconstructed contigs, whereas the Bit scores allow to estimate the distances between the reconstructed contigs and the subject sequence.

The "hits" file contains the sequences of contig portions that produced significant alignment in the BLAST step (i.e. query hit sequences), flanked by additional contig nucleotides 5' and 3' to the hit (the size of these margins is set to 5 by default and can be modified by the user). These margins allow to include sequences that might not have significant homology but could still be of viral origin.

Finally, the "Blast aligned sequences" file contains contigs that produced significant blast hits, whereas the "Blast unaligned sequences" file contains those that did not.

(iv) Blast-Guided Scaffolding {#sec009}
-----------------------------

This last task allows to integrate hit sequences matching a candidate virus into a virus scaffold ([Fig 1](#pone.0168397.g001){ref-type="fig"}). First, blastn or blastx hits are retrieved from the "hits" file using the tool "Pick Fasta sequences" ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}) and the appropriate query string (for instance, "Dengue" will retrieve hit sequences that significantly blast aligned with Dengue virus sequences). Next, these hit sequences can be further clustered in longer contigs using the "cap3 Sequence Assembly" Galaxy tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}) adapted from CAP3 \[[@pone.0168397.ref026]\]. Finally, if there are still multiple unlinked contigs at this stage, they can be integrated (uppercase characters) in the matched viral sequence taken as a scaffold (lowercase characters). This scaffolding is achieved by (a) retrieving the viral sequence from the NCBI nucleotide database to be used as the backbone of the scaffold, generating a blast index from this sequence and aligning the contigs to this index with blastn or tblastx tools (b) running the "blast_to_scaffold" tools ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}), taking as inputs the contigs, the viral guide sequence and the blastn or blastx output ([Fig 1](#pone.0168397.g001){ref-type="fig"}, bottom).

Availability of Metavisitor {#sec010}
---------------------------

All Metavisitor tools, workflows and use cases are available on the Galaxy server [[http://mississippi.snv.jussieu.fr](http://mississippi.snv.jussieu.fr/)]{.ul}. Readers can import in their personal account the published Metavisitor use case histories and their corresponding workflows to re-run the described analyses or adapt them to their studies.

We made all tools and workflows that compose Metavisitor available from the main Galaxy tool shed ([<https://toolshed.g2.bx.psu.edu/>]{.ul}), in the form of a tool suite (suite_metavisitor_1\_2) which thus can be installed and used on any Galaxy server instance. The Metavisitor workflows are also available from the *myexperiment* repository ([<http://www.myexperiment.org/>]{.ul}) They can be freely modified or complemented with additional analysis steps within the Galaxy environment.

The Metavisitor tool codes are accessible in our public GitHub repository ([<https://github.com/ARTbio/tools-artbio/>]{.ul}). We also provide a Docker image artbio/metavisitor:1.2 as well as an ansible playbook that both allow to deploy a Galaxy server instance with preinstalled Metavisitor tools and workflows in local infrastructures. Extensive documentation on how to install and use Metavisitor is available at <https://artbio.github.io/Metavisitor-manual/>.

Results {#sec011}
=======

The strategy implemented by Metavisitor ([Fig 1](#pone.0168397.g001){ref-type="fig"}) is to perform *de novo* assembly of sequencing reads and to detect contigs of viral origin through blast alignments to a nucleotide or protein sequence database of known viruses (vir1). These contig alignments can be further clustered to reconstruct a viral genome.

Below, we report use cases to demonstrate the use of Metavisitor in specific situations. For each use case, we briefly present the purpose of the original study from which the datasets originate and we describe an adapted Metavisitor workflow as well as its main outputs. Readers can further examine the workflows (<https://mississippi.snv.jussieu.fr/workflow/list_published>) and use case analyses (<https://mississippi.snv.jussieu.fr/history/list_published>) in every detail at [http://mississippi.fr](http://mississippi.fr/). Indicative execution times of the workflows are given in [S2 Table](#pone.0168397.s039){ref-type="supplementary-material"}.

1. Detection of known viruses {#sec012}
-----------------------------

### Use Cases 1--1, 1--2 and 1--3: detection and reconstruction of the Nora virus genome in small RNA sequencing datasets {#sec013}

Using small RNA sequencing libraries SRP013822 (EBI ENA) and the Paparazzi software \[[@pone.0168397.ref004]\] we were previously able to propose a novel reference genome (NCBI JX220408) for the Nora virus strain infecting *Drosophila melanogaster* stocks in laboratories \[[@pone.0168397.ref003]\]. This so-called rNora genome differed by 3.2% nucleotides from the Nora virus reference NC_007919.3 and improved the alignment rate of viral siRNAs by \~121%. Thus, we first tested Metavisitor on the small RNA sequencing datasets SRP013822 using the Oases *de novo* assembly tool which is well suited to assembly of short read \[[@pone.0168397.ref009]\].

Three Metavisitor workflows were run on the merged SRP013822 small RNA sequence reads and the NC_007919.3 genome as a guide for final scaffolding. The workflow for Use Case 1--1 ([S3 Fig](#pone.0168397.s003){ref-type="supplementary-material"}) used raw reads collapsed to unique sequences (experimental procedures) to reconstruct a Nora virus genome referred to as Nora_MV ([S1 File](#pone.0168397.s018){ref-type="supplementary-material"}). In a second workflow for Use Case 1--2 ([S4 Fig](#pone.0168397.s004){ref-type="supplementary-material"}), we did not collapse the SRP013822 reads to unique sequences, which allowed the reconstruction of a Nora_raw_reads genome ([S2 File](#pone.0168397.s019){ref-type="supplementary-material"}). Finally, the workflow for Use Case 1--3 ([S5 Fig](#pone.0168397.s005){ref-type="supplementary-material"}) normalized the abundances of SRP013822 sequence reads using the Galaxy tool "Normalize by median" \[[@pone.0168397.ref027]\] and reconstructed a Nora_Median-Norm-reads genome ([S3 File](#pone.0168397.s020){ref-type="supplementary-material"}).

All three reconstructed genomes as well as the Paparazzi-reconstructed JX220408 genome had a high sequence similarity (\>96.6% nucleotide identity) with the NC_007919.3 guide genome ([S4 File](#pone.0168397.s021){ref-type="supplementary-material"}). The final *de novo* (capital letters) assemblies of both the Nora_raw_reads and Nora_Median-Norm-reads genomes entirely covered the JX220408 and NC_007919.3 genomes (both 12333 nt), whereas the *de novo* assembled part of the Nora_MV genome was marginally shorter (12298 nt, the 31 first 5' nucleotides are in lowercase to indicate that they were not *de novo* assembled but instead recovered from the guide genome). To evaluate the quality of assemblies, we remapped the SRP013822 reads to the 3 reconstituted Nora virus genomes as well as to the JX220408 guide genome using the "workflow for remapping in Use Cases 1--1,2,3" ([S6 Fig](#pone.0168397.s006){ref-type="supplementary-material"}). As can be seen in [Fig 2](#pone.0168397.g002){ref-type="fig"}, SRP013822 reads matched the genomes with almost identical profiles and had characteristic size distributions of viral siRNAs with a major peak at 21 nucleotides. Importantly, the numbers of reads re-matched to the Nora virus genomes were 1,578,704 (Nora_MV) \> 1,578,135 (Paparazzi---JX220408) \> 1,566,909 (Nora_raw_reads) \> 1,558,000 (Nora_Median-Norm-reads) \> 872,128 (NC_007919.3 reference genome guide).

![Realignments of small RNA sequence reads to reconstructed (Nora_MV, Nora_raw_reads and Nora_Median−Norm−reads) or published (JX220408.1 and NC_007919.3) Nora virus genomes.\
Plots (left) show the abundance of 18--30-nucleotide (nt) small RNA sequence reads matching the genome sequences and histograms (middle) show length distributions of these reads. Positive and negative values correspond to sense and antisense reads, respectively. Total read counts are indicated to the right hand side.](pone.0168397.g002){#pone.0168397.g002}

Thus, Metavisitor reconstructed a Nora virus genome Nora_MV whose sequence maximizes the number of vsiRNA read alignments which suggests it is the most accurate genome for the Nora virus present in the datasets. Of note, the Nora_MV genome differs from the JX220408 rNora genome generated by Paparazzi by only two mismatches at positions 367 and 10707, and four 2nt-deletions at positions 223, 365, 9059 and 12217 (see [S4 File](#pone.0168397.s021){ref-type="supplementary-material"}). These variations did not change the amino acid sequence of the 4 ORFs of the Nora virus. We conclude that Metavisitor performs slightly better than Paparazzi for a known virus, using *de novo* assembly of small RNA reads followed by blast-guided scaffolding. We did not observe any benefits of using raw reads or normalized-by-median reads for *de novo* assembly with Oases, but rather a decrease in the accuracy of the reconstructed genome as measured by the number of reads re-mapped to the final genomes ([Fig 2](#pone.0168397.g002){ref-type="fig"}).

### Use Case 1--4: detection of multiple viruses in small RNA sequencing datasets {#sec014}

In order to show the ability of Metavisitor in detecting multiple known viruses in small RNA sequencing datasets, we built another workflow [Case](https://mississippi.snv.jussieu.fr/u/drosofff/w/metavisitor-workflow-for-use-case-1-1-imported-from-uploaded-file-1) that performs blastn alignments of Oases contigs on the vir1 reference and reports for all significant alignments without filtering ([S7 Fig](#pone.0168397.s007){ref-type="supplementary-material"}). Applying this workflow to the SRP013822 sequence datasets produced a list of alignments which contains, as expected, the Nora virus. In addition, contigs were found to align with high significance (Mean BitScore \> 200) to the Drosophila A virus and to the Drosophila C virus ([S5 File](#pone.0168397.s022){ref-type="supplementary-material"} and [Table 1](#pone.0168397.t001){ref-type="table"}), strongly suggesting that the fly stocks analyzed in our previous work were also subject to persistent infection by these viruses \[[@pone.0168397.ref003]\].

10.1371/journal.pone.0168397.t001

###### Report table generated by the "Parse blast output and compile hits" tool in Use Case 1--4 showing the presence of *Drosophila* A virus and *Drosophila* C virus in addition to the Nora virus in the small RNA sequencing of laboratory *Drosophila*.

See Method section for a description of the columns.

![](pone.0168397.t001){#pone.0168397.t001g}

  subject                                                                                                         subject length   Total Subject Coverage (nt)   Relative Subject Coverage   Best Bit Score   Mean Bit Score
  --------------------------------------------------------------------------------------------------------------- ---------------- ----------------------------- --------------------------- ---------------- ----------------
  gi\|157325505\|gb\|DQ321720.2\|\_Nora_virus,\_complete_genome                                                   11908            10211                         0.857                       11840            4041
  gi\|822478532\|gb\|KP970099.1\|\_Nora_virus_isolate_RAKMEL13_gp1\_(gp1)\_gene,\_partial_cds;\_and_replicatio    11416            8736                          0.765                       11441            3673
  gi\|822478537\|gb\|KP970100.1\|\_Nora_virus_isolate_GEO58_gp1\_(gp1)\_gene,\_partial_cds;\_and_replication_p    11416            2463                          0.216                       4028             3607
  gi\|346421290\|ref\|NC_007919.3\|\_Nora_virus,\_complete_genome                                                 12333            10530                         0.854                       11809            2653
  gi\|284022350\|gb\|GQ257737.1\|\_Nora_virus_isolate_Umea_2007,\_complete_genome                                 12333            10530                         0.854                       11809            2573
  gi\|822478527\|gb\|KP970098.1\|\_Nora_virus_isolate_AM04_gp1\_(gp1)\_gene,\_partial_cds;\_and_replication_po    11413            7654                          0.671                       5745             2489
  gi\|822478512\|gb\|KP970095.1\|\_Nora_virus_isolate_RAK11_gp1\_(gp1)\_and_replication_polyprotein\_(gp2)\_ge    11416            6174                          0.541                       5368             2419
  gi\|822478141\|gb\|KP969947.1\|\_Drosophila_A\_virus_isolate_ywiP_DrosophilaA_RNA-dependent_RNA_polymeras       4516             4157                          0.921                       6980             2361
  gi\|402295620\|gb\|JX220408.1\|\_Nora_virus_isolate_FR1,\_complete_genome                                       12333            12302                         0.997                       12720            2324
  gi\|822478147\|gb\|KP969949.1\|\_Drosophila_A\_virus_isolate_delta11_DrosophilaA_RNA-dependent_RNA_polyme       4481             4442                          0.991                       7081             2264
  gi\|822478417\|gb\|KP970078.1\|\_Nora_virus_isolate_D167_gp1\_(gp1),\_replication_polyprotein\_(gp2),\_gp3\_(   11895            7315                          0.615                       5503             2192
  gi\|822478517\|gb\|KP970096.1\|\_Nora_virus_isolate_K09_gp1\_(gp1)\_gene,\_partial_cds;\_and_replication_pol    11419            2027                          0.178                       3490             2050
  gi\|822478144\|gb\|KP969948.1\|\_Drosophila_A\_virus_isolate_XIB_DrosophilaA_RNA-dependent_RNA_polymerase       4516             4507                          0.998                       7092             2009
  gi\|822478150\|gb\|KP969950.1\|\_Drosophila_A\_virus_isolate_Qdelta_DrosophilaA_RNA-dependent_RNA_polymer       4476             4446                          0.993                       7092             1847
  gi\|822478440\|gb\|KP970082.1\|\_Nora_virus_isolate_RAKMEL12_gp1\_(gp1),\_replication_polyprotein\_(gp2),\_g    11968            7214                          0.603                       6396             1815
  gi\|822478497\|gb\|KP970092.1\|\_Nora_virus_isolate_delta11_gp1\_(gp1)\_gene,\_partial_cds;\_replication_pol    11157            2347                          0.210                       3314             1695
  gi\|822478522\|gb\|KP970097.1\|\_Nora_virus_isolate_JJ17_gp1\_(gp1)\_gene,\_partial_cds;\_and_replication_po    11420            993                           0.087                       1674             1659
  gi\|822478482\|gb\|KP970089.1\|\_Nora_virus_isolate_IM13_gp1\_(gp1)\_gene,\_partial_cds;\_replication_polypr    11103            1828                          0.165                       1977             1565
  gi\|225356593\|gb\|FJ150422.1\|\_Drosophila_A\_virus_isolate_HD,\_complete_genome                               4806             4753                          0.989                       6902             1419
  gi\|822478430\|gb\|KP970080.1\|\_Nora_virus_isolate_MONSIM03_gp1\_(gp1),\_replication_polyprotein\_(gp2),\_g    11968            2086                          0.174                       2993             1416
  gi\|822478445\|gb\|KP970083.1\|\_Nora_virus_isolate_SAF04_gp1\_(gp1),\_replication_polyprotein\_(gp2),\_gp3\_   11142            649                           0.058                       1121             1121
  gi\|822478135\|gb\|KP969945.1\|\_Drosophila_A\_virus_isolate_XID_DrosophilaA_RNA-dependent_RNA_polymerase       4516             4074                          0.902                       3103             1112
  gi\|822478403\|gb\|KP970076.1\|\_Nora_virus_isolate_ATH56_gp1\_(gp1)\_and_replication_polyprotein\_(gp2)\_ge    11965            2344                          0.196                       2812             1025
  gi\|822478412\|gb\|KP970077.1\|\_Nora_virus_isolate_IM09_gp1\_(gp1),\_replication_polyprotein\_(gp2),\_gp3\_(   11965            3689                          0.308                       2989             1023
  gi\|822478435\|gb\|KP970081.1\|\_Nora_virus_isolate_MON28_gp1\_(gp1)\_and_replication_polyprotein\_(gp2)\_ge    11967            5859                          0.490                       5445             1004
  gi\|822478507\|gb\|KP970094.1\|\_Nora_virus_isolate_K02_gp1\_(gp1)\_gene,\_partial_cds;\_replication_polypro    11160            1289                          0.116                       957              778
  gi\|822478132\|gb\|KP969944.1\|\_Drosophila_A\_virus_isolate_wipe_DrosophilaA_RNA-dependent_RNA_polymeras       4516             3070                          0.680                       3097             742
  gi\|822478477\|gb\|KP970088.1\|\_Nora_virus_isolate_IM12_gp1\_(gp1)\_gene,\_partial_cds;\_replication_polypr    11413            952                           0.083                       1153             732
  gi\|253761971\|ref\|NC_012958.1\|\_Drosophila_A\_virus,\_complete_genome                                        4806             607                           0.126                       1045             674
  gi\|822478542\|gb\|KP970101.1\|\_Nora_virus_isolate_SAFSIM01_gp1\_(gp1)\_gene,\_partial_cds;\_and_replicatio    11413            384                           0.034                       661              661
  gi\|822478138\|gb\|KP969946.1\|\_Drosophila_A\_virus_isolate_LJ35_DrosophilaA_RNA-dependent_RNA_polymeras       4468             959                           0.215                       848              502
  gi\|9629650\|ref\|NC_001834.1\|\_Drosophila_C\_virus,\_complete_genome                                          9264             6345                          0.685                       1276             445
  gi\|2388672\|gb\|AF014388.1\|\_Drosophila_C\_virus_strain_EB,\_complete_genome                                  9264             6587                          0.711                       1276             431
  gi\|300871949\|gb\|GU983882.2\|\_Drosophila_C\_virus_isolate_ZW141_polyprotein_gene,\_partial_cds               500              272                           0.544                       482              395
  gi\|300871965\|gb\|GU983892.2\|\_Drosophila_C\_virus_isolate_psjmg_polyprotein_gene,\_partial_cds               500              310                           0.620                       491              353
  gi\|300871979\|gb\|GU983900.2\|\_Drosophila_C\_virus_isolate_AL7_polyprotein_gene,\_partial_cds                 500              271                           0.542                       489              342
  gi\|300871957\|gb\|GU983888.2\|\_Drosophila_C\_virus_isolate_Bam73_H\_polyprotein_gene,\_partial_cds            500              453                           0.906                       491              323
  gi\|300871941\|gb\|GU983878.2\|\_Drosophila_C\_virus_isolate_mel15_H\_polyprotein_gene,\_partial_cds            500              453                           0.906                       489              321
  gi\|300871955\|gb\|GU983885.2\|\_Drosophila_C\_virus_isolate_16a9_polyprotein_gene,\_partial_cds                490              151                           0.308                       273              262
  gi\|300871953\|gb\|GU983884.2\|\_Drosophila_C\_virus_isolate_Tam15_polyprotein_gene,\_partial_cds               500              151                           0.302                       273              262

2. Discovery of novel viruses {#sec015}
-----------------------------

### Use Case 2--1: identification of new viruses in small RNA sequencing datasets {#sec016}

Using Metavisitor, we recently discovered two novel viruses infecting a laboratory colony of *Anopheles coluzzii* mosquitoes \[[@pone.0168397.ref028]\]. In this case, a workflow ([S8 Fig](#pone.0168397.s008){ref-type="supplementary-material"}) was used to process small RNA datasets from these mosquitoes (EBI SRA ERP012577) and to assemble a number a Oases contigs that show significant blastx hits with *Dicistroviridae* proteins, including *Drosophila* C virus (DCV) and Cricket paralysis virus (CrPV) proteins ([S6 File](#pone.0168397.s023){ref-type="supplementary-material"}).

The viral family of *Dicistroviridae* was named from the dicistronic organisation of their genome with a 5' open reading frame encoding a non-structural polyprotein and a second non-overlapping 3' open reading frame encoding the structural polyprotein. In order to construct a potential new *A*. *coluzzii* dicistrovirus genome, the "Pick Fasta Sequences" tool ([S8 Fig](#pone.0168397.s008){ref-type="supplementary-material"}) collected blastx hits showing significant alignment with both *Drosophila* C virus and Cricket paralysis viral polyproteins ([S7 File](#pone.0168397.s024){ref-type="supplementary-material"}) that were further clustered with the "cap3 Sequence Assembly" tool in 4 contigs of 1952, 341, 4688 and 320 nt, respectively ([S8 File](#pone.0168397.s025){ref-type="supplementary-material"}). These 4 contigs were further aligned to the DCV genome NC_001834.1 sequence with tblastx and integrated in this scaffold sequence with the "blast_to_scaffold" tool to produce a final assembly ([S9 File](#pone.0168397.s026){ref-type="supplementary-material"}). Re-mapping of the ERP012577 small RNA reads using the "Workflow for remapping in Use Cases 1--1,2,3" ([S6 Fig](#pone.0168397.s006){ref-type="supplementary-material"}) showed that they mostly align to *de novo* assembled regions (uppercase nucleotides) of this chimeric genome and have a typical size distribution of viral derived siRNA ([S9 Fig](#pone.0168397.s009){ref-type="supplementary-material"}), suggesting that the NC_001834.1 DCV sequences of the scaffold (lowercase nucleotides) are loosely related to the actual sequence of the novel *A*. *coluzzii* dicistrovirus. Nevertheless, the composite assembly allowed designing primers in the *de novo* assembled regions to PCR amplify and sequence the regions of the viral genome that could not be *de novo* assembled \[[@pone.0168397.ref028]\].

Several teams have used siRNA signature (a peak at 21 nt in the size distribution of re-aligned small RNA sequences) as an alternate approach to sequence similarity to identify contigs of potential viral origin \[[@pone.0168397.ref012],[@pone.0168397.ref013]\]. In order to further illustrate the flexibility of Metavisitor for implementing this strategy, we built a workflow ([S10 Fig](#pone.0168397.s010){ref-type="supplementary-material"}) to realign ERP012577 small RNA sequences to Oases contigs of length higher than 300 nt and to generate in batch read maps and read size distributions for these contigs using the "Generate readmap and histograms from alignment files" tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}). We manually inspected these read maps and size distributions ([S10 File](#pone.0168397.s027){ref-type="supplementary-material"}) and collected all contigs with a clear siRNA signature (a pick at 21nt for both forward and reverse strands of contig sequences), 2 sets of contigs with a modest excess of 21nt reads from the forward strand only and 3 sets of contigs with no siRNA signature as negative controls ([S3 Table](#pone.0168397.s040){ref-type="supplementary-material"}). With the notable exceptions of loci 3 and 46 contigs, all contigs with a clear siRNA signature blastx aligned to vir1 viral sequences ([S3 Table](#pone.0168397.s040){ref-type="supplementary-material"} and see [here](https://mississippi.snv.jussieu.fr/u/drosofff/h/small-rna-profiling-of-oases-contigs-use-case-2-1) the public Galaxy history for details). Loci 3 and 46 contigs did not align either to the non-redundant protein database of the NCBI and may therefore be of potential viral origin ([S3 Table](#pone.0168397.s040){ref-type="supplementary-material"}). All 5 negative control contigs with unclear or no RNA signature only aligned significantly to non-viral proteins ([S3 Table](#pone.0168397.s040){ref-type="supplementary-material"}). Together, these results illustrate the use of Metavisitor to implement a sequence-independent strategy based on siRNAs for virus identification \[[@pone.0168397.ref012],[@pone.0168397.ref013]\].

### Use Case 2--2: identification of new viruses in mRNA sequencing datasets {#sec017}

In our study \[[@pone.0168397.ref028]\], we also used RNAseq libraries from the same *A*. *coluzzii* colony (EBI-SRA, ERS977505), demonstrating the use of a Metavisitor workflow for long RNA sequencing read datasets ([S11 Fig](#pone.0168397.s011){ref-type="supplementary-material"}). Thus, 100nt reads were aligned without adapter clipping to the *Anopheles gambiae* genome using bowtie2, and unmatched read were subjected to Oases assembly (kmer range 25 to 69, to take into account longer reads). Oases contigs were then filtered for a size \> 5000 nt and aligned to the protein viral reference using blastx. Parsing of blastx alignments with the "blast analysis, by subjects" tool repeatedly pointed to a 8919nt long Oases contig that matched to structural and non-structural polyproteins of DCV and CrPV ([S11 File](#pone.0168397.s028){ref-type="supplementary-material"}). This 8919nt contig ([S12 File](#pone.0168397.s029){ref-type="supplementary-material"}) completely includes the contigs generated with the small RNA datasets ([S8 File](#pone.0168397.s025){ref-type="supplementary-material"}) and shows a dicistronic organization which is typical of Dicistroviridae and is referred to as a novel *Anopheles* C Virus \[[@pone.0168397.ref028]\]. The sequence of this *Anopheles* C Virus is deposited to the NCBI nucleotide database under accession number KU169878. As expected, when realigned to this genome ([S12 Fig](#pone.0168397.s012){ref-type="supplementary-material"}), the ERP012577 small RNA reads now show a typical alignment profile all along the AnCV genome sequence with a size distribution peaking at the 21nt length of viral derived siRNAs and no gap ([Fig 3](#pone.0168397.g003){ref-type="fig"}). Of note, we tested in Use Case 2--2 two alternate workflows substituting the Oases assembly tool with Trinity ([S13 Fig](#pone.0168397.s013){ref-type="supplementary-material"}) and SPAdes ([S14 Fig](#pone.0168397.s014){ref-type="supplementary-material"}), respectively. Both these workflows were equally able to assemble the genome KU169878 of the Anopheles C Virus ([S13 File](#pone.0168397.s030){ref-type="supplementary-material"}).

![Alignments of small RNA sequence reads to the Anopheles C virus genome reconstructed in Use Case 2--2.\
Plot shows the abundance of 18--30-nucleotide (nt) small RNA sequence reads matching the genome sequence and histogram shows the length distribution of these reads. Positive and negative values correspond to sense and antisense reads, respectively.](pone.0168397.g003){#pone.0168397.g003}

Taken together, the Metavisitor Use Cases 2--1 and 2--2 illustrate that when short read datasets do not provide enough sequencing information, an adapted Metavisitor workflow ([S11 Fig](#pone.0168397.s011){ref-type="supplementary-material"}) is able to exploit long reads of RNA sequencing datasets, if available, to assemble a complete viral genome \[[@pone.0168397.ref028]\].

3. Virus detection in human RNAseq libraries {#sec018}
--------------------------------------------

Having illustrated that Metavisitor is able to generate robust genome assemblies from known and novel viruses in *Drosophila* and *Anopheles* sequencing datasets, we tested whether it can be used to diagnose viruses in RNA sequencing datasets of human patients from three different studies \[[@pone.0168397.ref029]--[@pone.0168397.ref031]\].

### Use Case 3--1 {#sec019}

Innate lymphoid cells (ILCs) play a central role in response to viral infection by secreting cytokines crucial for immune regulation, tissue homeostasis, and repair. Therefore, the pathogenic effect of HIV on these cells was recently analyzed in infected or uninfected patients using various approaches, including transcriptome profiling \[[@pone.0168397.ref030]\]. ILCs are unlikely to be infected *in vivo* by HIV as they lack expression of the CD4 co-receptor of HIV and they are refractory *in vitro* to HIV infection. However, we reasoned that ILCs samples could still be contaminated by infected cells. This might allow Metavisitor to detect and assemble HIV genomes from patient's ILC sequencing data (EBI SRP068722).

We imported 40 ICL sequence datasets from the EBI SRP068722 archive and merged the datasets belonging to the same patients. As the data contained short 32 nt reads that in addition had to be 3' trimmed to 27 nt to retain acceptable sequence quality, we designed a workflow for Use Case 3--1 ([S15 Fig](#pone.0168397.s015){ref-type="supplementary-material"}) that is similar to the workflows used in cases 1--1 and 2--1 for small RNA sequencing data. Thus, the sequencing datasets were depleted from reads aligning to the human genome (hg19) and viral reads were selected by alignment to the NCBI viral sequences using the sRbowtie tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}). These reads were further submitted to Oases assembly (kmers 11 to 27, to take into account short reads) and the resulting contigs were aligned to the Nucleotide Viral Blast Database using blastn. Alignments were parsed using the "Parse blast output and compile hits" tool, removing alignments to NCBI sequences related to patents to simplify the report ("Patent" term in the filter option of the "Parse blast output and compile hits" tool). A final report was generated by concatenating the reports produced by this tool for each patient [(](https://mississippi.snv.jussieu.fr/u/drosofff/h/metavisitor-history-for-use-case-3-1-1)[S14 File](#pone.0168397.s031){ref-type="supplementary-material"} and [Table 2](#pone.0168397.t002){ref-type="table"}[)](https://mississippi.snv.jussieu.fr/u/drosofff/h/metavisitor-history-for-use-case-3-1-1). In summary, we were able to detect HIV RNAs in samples from 3 out of 4 infected patients whereas all samples from control uninfected patients remained negative for HIV. This Metavisitor workflow was able to accurately detect HIV RNA, even in samples where the number of sequence reads was expected to be low.

10.1371/journal.pone.0168397.t002

###### HIV detection in ILC patient samples of Use Case 3--1.

The table summarizes the report generated by Metavisitor from a batch of 40 sequence datasets (S14 File). Metadata associated with each indicated sequence dataset as well as the ability of Metavisitor to detect HIV in datasets and patients are indicated.
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  \# GSM ID    ID-1     Patient          Treatment (SRR annotations)   HIV status   Days post HIV infection   Treat. status   SRR ID       Metavisitor HIV detection by sample   number of raw reads   number of raw reads by patient   History for Use Case 3--1
  ------------ -------- ---------------- ----------------------------- ------------ ------------------------- --------------- ------------ ------------------------------------- --------------------- -------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GSM2043730   110314   0450--318        ILC2                          HIV+         1                         untreated       SRR3111582   \+                                    7 013 962             34 252 732                       gi\|45357423\|gb\|AY535449.1, gi\|45357419\|gb\|AY535447.1
  GSM2043731   110314   0450--318        ILC3                          HIV+         1                         untreated       SRR3111583   \-                                    3 246 980                                              
  GSM2043732   180314   0450--318        ILC2                          HIV+         7                         untreated       SRR3111584   \+                                    2 833 634                                              
  GSM2043733   180314   0450--318        ILC3                          HIV+         7                         untreated       SRR3111585   \+                                    2 989 628                                              
  GSM2043734   170414   0450--318        ILC2                          HIV+         38                        untreated       SRR3111586   \-                                    16 248 912                                             
  GSM2043735   170414   0450--318        ILC3                          HIV+         38                        untreated       SRR3111587   \-                                    1 919 616                                              
  GSM2043736   110614   0387--272        ILC2                          HIV+         1                         untreated       SRR3111588   \-                                    60 342 796            227 307 414                      \-
  GSM2043737   110614   0387--272        ILC3                          HIV+         1                         untreated       SRR3111589   \-                                    34 189 278                                             
  GSM2043738   170614   0387--272        ILC2                          HIV+         7                         untreated       SRR3111590   \-                                    38 030 394                                             
  GSM2043739   170614   0387--272        ILC3                          HIV+         7                         untreated       SRR3111591   \-                                    29 100 534                                             
  GSM2043740   290714   0387--272        ILC2                          HIV+         49                        untreated       SRR3111592   \-                                    43 022 506                                             
  GSM2043741   290714   0387--272        ILC3                          HIV+         49                        untreated       SRR3111593   \-                                    22 621 906                                             
  GSM2043742   41214    0629--453        Acute ART+ ILC2               HIV+         1                         ART             SRR3111594   \+                                    5 061 920             54 052 098                       gi\|296033826\|gb\|GU474419.1, gi\|269294806\|dbj\|DM461231.1, gi\|269294805\|dbj\|DM461230.1, gi\|296556482\|gb\|AF324493.2gi\|296556485\|gb\|M19921.2, gi\|45357419\|gb\|AY535447.1, gi\|45357423\|gb\|AY535449.1
  GSM2043743   41214    0629--453        Acute ART+ ILC3               HIV+         1                         ART             SRR3111595   \-                                    8 455 026                                              
  GSM2043744   101214   0629--453        Acute ART+ ILC2               HIV+         6                         ART             SRR3111596   \-                                    12 451 684                                             
  GSM2043745   101214   0629--453        Acute ART+ ILC3               HIV+         6                         ART             SRR3111597   \+                                    6 419 868                                              
  GSM2043746   130115   0629--453        Acute ILC2                    HIV+         40                        ART             SRR3111598   \+                                    6 837 584                                              
  GSM2043747   130115   0629--453        Acute ILC3                    HIV+         40                        ART             SRR3111599   \+                                    14 826 016                                             
  GSM2043748   150714   0444--312        3dR10 ILC2                    HIV+         2                         ART             SRR3111600   \+                                    15 618 282            39 610 902                       gi\|45357423\|gb\|AY535449.1, gi\|45357419\|gb\|AY535447.1
  GSM2043749   150714   0444--312        3dR10 ILC3                    HIV+         2                         ART             SRR3111601   \+                                    13 491 804                                             
  GSM2043750   220814   0444--312        ILC2                          HIV+         41                        ART             SRR3111602   \-                                    5 259 104                                              
  GSM2043751   220814   0444--312        ILC3                          HIV+         41                        ART             SRR3111603   \-                                    5 241 712                                              
  GSM2043752   10814    0500-355neg      ILC2                          HIV-         uninfected                none            SRR3111604   \-                                    802 632               11 691 304                       \-
  GSM2043753   10814    0500-355neg      ILC3                          HIV-         uninfected                none            SRR3111605   \-                                    10 888 672                                             
  GSM2043754   80814    0292-xxxneg      ILC2                          HIV-         uninfected                none            SRR3111606   \-                                    5 418 958             19 222 152                       \-
  GSM2043755   80814    0292-xxxneg      ILC3                          HIV-         uninfected                none            SRR3111607   \-                                    13 803 194                                             
  GSM2043756   90714    0394--274        ILC2                          HIV-         uninfected                none            SRR3111608   \-                                    13 779 570            15 991 428                       \-
  GSM2043757   90714    0394--274        ILC3                          HIV-         uninfected                none            SRR3111609   \-                                    2 211 858                                              
  GSM2043758   170714   0218-162neg      ILC2                          HIV-         uninfected                none            SRR3111610   \-                                    9 838 776             18 939 560                       \-
  GSM2043759   170714   0218-162neg      ILC3                          HIV-         uninfected                none            SRR3111611   \-                                    9 100 784                                              
  GSM2043760   180314   0311-217HIVneg   ILC2                          HIV-         uninfected                none            SRR3111612   \-                                    2 281 560             7 490 832                        \-
  GSM2043761   180314   0311-217HIVneg   ILC3                          HIV-         uninfected                none            SRR3111613   \-                                    5 209 272                                              
  GSM2043762   230514   0440-307neg      ILC2                          HIV-         uninfected                none            SRR3111614   \-                                    11 816 186            21 714 164                       \-
  GSM2043763   230514   0440-307neg      ILC3                          HIV-         uninfected                none            SRR3111616   \-                                    9 897 978                                              
  GSM2043764   240614   0518-370neg      ILC2                          HIV-         uninfected                none            SRR3111617   \-                                    16 135 602            16 671 200                       \-
  GSM2043765   240614   0518-370neg      ILC3                          HIV-         uninfected                none            SRR3111618   \-                                    535 598                                                
  GSM2043766   290714   0560-420neg      ILC2                          HIV-         uninfected                none            SRR3111619   \-                                    1 235 766             12 912 002                       \-
  GSM2043767   290714   0560-420neg      ILC3                          HIV-         uninfected                none            SRR3111620   \-                                    11 676 236                                             
  GSM2043768   290714   0575-419neg      ILC2                          HIV-         uninfected                none            SRR3111621   \-                                    8 713 816             11 833 416                       \-
  GSM2043769   290714   0575-419neg      ILC3                          HIV-         uninfected                none            SRR3111622   \-                                    3 119 600                                              

### Use Case 3--2 {#sec020}

Yozwiak *et al*. searched the presence of viruses in RNA Illumina sequencing data from serums of children suffering from fevers of unknown origins \[[@pone.0168397.ref029]\]. In this study, paired-end sequencing datasets were depleted from reads aligning to the human genome and the human transcriptome using BLAT and BLASTn, respectively, and the remaining reads were aligned to the NCBI nucleotide database using BLASTn. A virus was considered identified when 10 reads or more aligned to a viral genome which was not tagged as a known lab contaminant.

For a significant number of Patient IDs reported in [Table 1](#pone.0168397.t001){ref-type="table"} of the article \[[@pone.0168397.ref029]\], we were not able to find the corresponding sequencing files in the deposited EBI SRP011425 archive. In addition, we did not find the same read counts for these datasets as those indicated by the authors. With these limitations in mind, we downloaded 86 sequencing datasets that could be further concatenated and assigned to 36 patients in Yozwiak *et al* \[[@pone.0168397.ref029]\]. As sequence reads in SRP011425 datasets are 97 nt long, we adapted a workflow for this Use Case 3--2 ([S16 Fig](#pone.0168397.s016){ref-type="supplementary-material"}) from the one used in the Use Case 3--1 with the following modifications: (i) sequences reads were depleted from human sequences and viral reads were selected by alignment to the NCBI viral sequences using the Galaxy bowtie2 tool ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}) instead of the sRbowtie tool; (ii) viral reads were submitted to Oases assembly using kmer values ranging from 13 to 69 to take into account long reads; (iii) the SAM file with reads alignments to the vir1 bowtie2 index was parsed using the "join" and "sort" Galaxy tools in order to detect putative false negative datasets with viral reads that fails to produce significant Oases viral contigs.

This workflow generated a report file ([S15 File](#pone.0168397.s032){ref-type="supplementary-material"}) summarized in [Table 3](#pone.0168397.t003){ref-type="table"}. The results show that Metavisitor detected the same viruses as those reported by Yozwiak *et al*. in 17 patients. Although viral reads were detected in 16 other patients, they were not covering sufficient portions of viral genomes to produce significant viral assemblies. Finally, in the three remaining patients (patients 363, 330 and 345 in [Table 3](#pone.0168397.t003){ref-type="table"}), we detected viruses (Dengue virus 2, Stealth virus 1 and Dengue virus 4, respectively) other than those identified by Yozwiak *et al*. These discrepancies are most likely due to misannotation of some of the deposited datasets, which precludes further detailed comparisons.

10.1371/journal.pone.0168397.t003

###### Summary of virus detection in 36 traceable patients of the Use Case 3--2.

The Data of this table were extracted from the Metavisitor report file available as [S15 File](#pone.0168397.s032){ref-type="supplementary-material"}. Values of the column "Coverage of complete viral genome (%)" correspond to the fractions (in %) of the complete viral genomes that are covered by blast hits of viral contigs to these genomes and values of the column "Mean blast bit score" correspond to the mean values of the bit scores observed for these blast hits. Note that blast alignments to incomplete viral genomes were not taken into account. For detection of false positives, reads were aligned to the bowtie2 vir1 index before *de novo* assembly and counts of these reads were reported in the column "Read mapping to vir1 using bowtie2").
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  Extracted from Yozwiak et al. [Table 1](#pone.0168397.t001){ref-type="table"}   Metavisitor                                                                                                                                                                                                                                       
  ------------------------------------------------------------------------------- ------------- ---------- ---------- ----------------------------------------------- ---------- -------------------------------------------------------------- ------- -------- ------------------------------------------------------------------ ---------------------
  566                                                                             206           1.90E+06   1.08E-04   Torque teno mini virus 4                        1.07E+06   none                                                           \-      \-       No Significant alignments                                          SRR453487
  438                                                                             72            4.40E+06   1.64E-05   Human herpesvirus 6                             3.20E+06   Human herpesvirus 6                                            0.36    239.3    49 Human_herpesvirus_6                                             SRR453437
  401                                                                             2164          1.80E+05   1.20E-02   Hepatitis A virus                               9.94E+05   Hepatitis A virus                                              69.74   735.2    6154 reads Hepatitis_A\_virus                                      SRR453443,SRR453458
  382                                                                             44            9.60E+05   4.58E-05   Human herpesvirus 4                             2.33E+06   none                                                           \-      \-       38 Human_herpesvirus_4                                             SRR453430
  377                                                                             81            6.60E+06   1.23E-05   Cyclovirus PK5034                               4.91E+06   Circovirus-like_NI/2007-3                                      20.45   212.0    58 reads Circovirus-like_NI/2007-376 Torque teno virus             SRR453491
  375                                                                             53            3.80E+06   1.39E-05   Porcine circovirus 1                            2.65E+06   Circovirus-like_NI/2007-3                                      20.63   214.0    66 reads Circovirus-like_NI/2007-3                                 SRR453499
  350                                                                             48            3.00E+06   1.60E-05   Human herpesvirus 6, Torque teno mini virus 4   1.93E+06   none                                                           \-      \-       29 Human_herpesvirus_6128 Torque teno mini virus 4                 SRR453484
  349                                                                             47            1.60E+06   2.94E-05   Torque teno midi virus                          1.03E+06   none                                                           \-      \-       No Significant alignments                                          SRR453464
  345                                                                             62            2.20E+06   2.82E-05   Beak and feather disease virus                  1.29E+06   Dengue_virus_4                                                 0.81    156.0    159 Dengue_virus_465 Circovirus-like_NI/2007                       SRR453506
  344                                                                             303           1.30E+06   2.33E-04   Human herpesvirus 6                             7.48E+05   Human herpesvirus 6                                            0.17    304.0    184 Human_herpesvirus_6                                            SRR453417
  335                                                                             47            1.70E+06   2.76E-05   Torque teno virus                               9.77E+05   none                                                           \-      \-       24 Torque teno virus                                               SRR453490
  331                                                                             113           1.40E+06   8.07E-05   Torque teno midi virus 2                        8.99E+05   UNVERIFIED:\_Torque_teno_virus_isolate_S55,\_complete_genome   20.93   353.4    772 Torque teno virus                                              SRR453478
  330                                                                             77            1.80E+06   4.28E-05   TTV-like mini virus                             1.85E+06   AF191073_Stealth_virus_1\_clone_3B43                           2.68    143.0    14 reads Stealth_virus_1\_clone_C16130_T324 reads Dengue virus 2   SRR453465,SRR453480
  329                                                                             14            2.20E+06   6.36E-06   Gull circovirus                                 2.93E+06   Circovirus-like_NI/2007-3                                      53.64   339.5    5 reads Circovirus-like_NI/2007-312 reads Dengue virus 2           SRR453489,SRR453505
  322                                                                             206           3.80E+06   5.42E-05   Cyclovirus PK5222                               2.63E+06   Circovirus-like_NI/2007-3                                      25.35   257.0    208 reads Circovirus-like_NI/2007-3                                SRR453498
  321                                                                             30            4.60E+06   6.52E-06   Porcine circovirus 1                            3.54E+06   none                                                           \-      \-       10 reads Circovirus-like_NI/2007-317 reads Dengue virus 2          SRR453446
  315                                                                             42            1.90E+06   2.21E-05   African swine fever virus                       1.59E+06   none                                                           \-      \-       22 reads Dengue virus 2                                            SRR453427,SRR453440
  282                                                                             699           1.60E+06   4.20E-04   Dengue virus 2                                  9.66E+05   Dengue virus 2                                                 3.63    495.0    651 reads Dengue virus 2                                           SRR453438
  275                                                                             1511          1.60E+06   9.70E-04   Dengue virus 2                                  1.11E+06   Dengue virus 2                                                 10.23   539.2    1436 reads Dengue virus 2                                          SRR453450
  274                                                                             27            1.20E+06   2.30E-05   Dengue virus 1                                  6.24E+05   none                                                           \-      \-       28 reads Dengue virus 1/2                                          SRR453460
  270                                                                             28            1.20E+06   2.33E-05   Human herpesvirus 6                             6.76E+05   none                                                           \-      \-       20 Human_herpesvirus_6                                             SRR453485
  266                                                                             135749        4.80E+06   2.80E-02   Dengue virus 2                                  3.36E+06   Dengue virus 2                                                 98.65   1852.3   121347 reads Dengue virus 2                                        SRR453448
  263                                                                             ND            ND         ND         TTV (virochip)                                  3142332    Dengue virus 2                                                 39.19   302.0    75 densovirus92 Dengue virus                                       SRR453424,SRR453457
  193                                                                             56            1.60E+06   3.50E-05   Torque teno mini virus 2                        9.13E+05   none                                                           \-      \-       6 reads Torque_teno_virus_isolate_TTV-S34                          SRR453510
  187                                                                             4280          1.10E+06   3.90E-03   Dengue virus 2                                  5.55E+05   Dengue virus 2                                                 39.30   496.8    3970 reads Dengue virus 2                                          SRR453456
  186                                                                             1701          2.00E+06   8.51E-04   Torque teno virus 15                            1.32E+06   Torque teno virus (SEN virus)                                  55.85   389.4    541 SEN virus AY449524.127 reads Torque_teno_virus_15              SRR453425,SRR453469
  183                                                                             66            3.00E+06   2.20E-05   Human herpesvirus 6                             1.97E+06   none                                                           \-      \-       57 Human_herpesvirus_6B                                            SRR453481
  180                                                                             42            8.00E+05   5.25E-05   GB virus C                                      4.91E+06   GB virus C                                                     1.26    185.0    41 reads GB virus                                                  SRR453531
  179                                                                             17            1.80E+06   9.44E-06   Torque teno mini virus 1                        1.31E+06   none                                                           \-      \-       No Significant alignments                                          SRR453474
  171                                                                             18            1.20E+06   1.50E-05   Torque teno mini virus 2                        7.81E+05   none                                                           \-      \-       No Significant alignments                                          SRR453509
  168                                                                             ND            ND         ND         TTV (virochip)                                  135412     none                                                           \-      \-       No Significant alignments                                          SRR453451
  161                                                                             14            3.00E+06   4.67E-06   Human parvovirus B19                            2.75E+06   Human parvovirus B19                                           2.89    242.0    79 densovirus12 reads Human parvovirus B19                         SRR453495,SRR453504
  159                                                                             143           2.60E+06   5.50E-05   Torque teno mini virus 5                        1.73E+06   Uncultured virus DNA                                           88.14   339.0    No Significant alignments                                          SRR453500
  156                                                                             213           2.30E+06   9.26E-05   Torque teno midi virus 1                        1.54E+06   Torque_teno_virus                                              31.01   314.7    550 reads Torque_teno_virus_isolate_S54                            SRR453493
  131                                                                             24            1.20E+06   2.00E-05   Human herpesvirus 6                             5.46E+05   Human herpesvirus 6                                            0.18    263.0    16 reads Human_herpesvirus_6                                       SRR453444
  78                                                                              113           1.20E+06   9.42E-05   Human herpesvirus 6                             5.91E+05   none                                                           \-      \-       68 reads Human_herpesvirus_6B                                      SRR453426

### Use case 3--3 {#sec021}

Matranga *et al*. recently improved library preparation methods for deep sequencing of Lassa and Ebola viral RNAs in clinical and biological samples \[[@pone.0168397.ref031]\]. Accordingly, they were able to generate sequence datasets of 150 nt reads providing high coverage of the viral genomes. We used these datasets, relevant in the context of Lassa and Ebola outbreak and epidemic response, to demonstrate the versatility of Metavisitor as well as its ability to generate high throughput reconstruction of viral genomes.

In order to take into account longer reads and higher viral sequencing depths in the available datasets \[[@pone.0168397.ref031]\], we adapted a Metavisitor workflow for Use Case 3--3 ([S17 Fig](#pone.0168397.s017){ref-type="supplementary-material"}) as follows: (i) sequencing reads were directly aligned to vir1 sequences using bowtie2, without prior depletion by alignment to the human or rodent hosts; (ii) the Trinity *de novo* assembler \[[@pone.0168397.ref023]\] that performs well with longer reads was used instead of Oases ([S1 Table](#pone.0168397.s038){ref-type="supplementary-material"}); (iii) reconstruction of Lassa and Ebola genomes from the sequences of the blast hits with the nucleotide viral blast database was directly performed with the "blast to scaffold" tool without CAP3 assembly since the Trinity contigs were already covering a significant part of the viral genomes; (iv) the reports generated by our "Parse blast output and compile hits" tool as well as the reconstructed genome generated for each sample were merged in single datasets for easier browsing and subsequent phylogenetic or variant analyses; (v) for adaptability of this workflow to any type of virus, we allowed users to specify two input variables at runtime: the name of the virus to be searched for in the analysis and the identifier of the sequence to be used as guide in genome reconstruction steps.

We imported 63 sequence datasets available in the EBI SRA PRJNA254017 and PRJNA257197 archives \[[@pone.0168397.ref031]\] and grouped these datasets in Lassa virus (55 fastq files) and Ebola virus (8 fastq files) dataset collections (see [Table 4](#pone.0168397.t004){ref-type="table"} for description of the sequence datasets). On the one hand, we executed the workflow ([S17 Fig](#pone.0168397.s017){ref-type="supplementary-material"}) taking the Lassa virus dataset collection as input sequences, "Lassa" as a filter term for the "Parse blast output and compile hits" tool and the NCBI sequence NC_004297.1 as a guide for reconstruction of the Lassa virus segment L. On the other hand, we executed the workflow taking the Ebola virus dataset collection as input sequences, "Ebola" as a filter term for the "Parse blast output and compile hits" tool and the NCBI sequence NC_002549.1 as a guide for reconstruction of the Ebola virus genome.

10.1371/journal.pone.0168397.t004

###### Summary of detection of Ebola and Lassa viruses in Use Case 3--3.

The table summarizes the Metavisitor report files available as [S16](#pone.0168397.s033){ref-type="supplementary-material"} and [S17](#pone.0168397.s034){ref-type="supplementary-material"} Files.

![](pone.0168397.t004){#pone.0168397.t004g}

  Virus   BioProject    BioSample id   SRX number   SRR number   Sample ID         BAM file name                  Source     Data Type, Selection   Figure, Table from Matranga et al.              Metavisitor detection (Trinity)
  ------- ------------- -------------- ------------ ------------ ----------------- ------------------------------ ---------- ---------------------- ----------------------------------------------- ---------------------------------
  EBOV    PRJNA257197   SAMN03099684   SRX733660    SRR1613381   G3676-2           G3676-2_S6_L001_001.bam        Human      RNase H                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099684   SRX733656    SRR1613377   G3676-2           G3676-2-std_S13_L001_001.bam   Human      RNA seq                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099685   SRX733661    SRR1613382   G3677-1           G3677-1_S3_L001_001.bam        Human      RNase H                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099685   SRX733657    SRR1613378   G3677-1           G3677-1-std_S10_L001_001.bam   Human      RNA seq                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099686   SRX733662    SRR1613383   G3677-2           G3677-2_S2_L001_001.bam        Human      RNase H                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099686   SRX733658    SRR1613379   G3677-2           G3677-2-std_S9_L001_001.bam    Human      RNA seq                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099687   SRX733663    SRR1613384   G3682-1           G3682-1_S4_L001_001.bam        Human      RNase H                Figure 5                                        **+**
  EBOV    PRJNA257197   SAMN03099687   SRX733659    SRR1613380   G3682-1           G3682-1-std_S11_L001_001.bam   Human      RNA seq                Figure 5                                        **+**
  LASV    PRJNA254017   SAMN02927412   SRX719120    SRR1595772   G2431             LASV678_ERCC117                Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927412   SRX719079    SRR1595696   G2431             LASV678_ERCC12                 Human      RNA seq                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927488   SRX719056    SRR1595665   ISTH1003          LASV347_ERCC126                Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927488   SRX718926    SRR1595500   ISTH1003          LASV347_ERCC17                 Human      RNA seq                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927485   SRX718761    SRR1594619   ISTH0531          LASV334_ERCC136                Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927485   SRX719205    SRR1595943   ISTH0531          LASV334_ERCC31                 Human      RNA seq                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927498   SRX719063    SRR1595673   ISTH1121          LASV363_ERCC69                 Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927498   SRX719134    SRR1595797   ISTH1121          LASV363_ERCC43                 Human      RNA seq                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927489   SRX719117    SRR1595763   ISTH1038          LASV349_ERCC62                 Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927489   SRX718979    SRR1595558   ISTH1038          LASV349_ERCC42                 Human      RNA seq                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927510   SRX718802    SRR1594664   ISTH2050          LASV386_ERCC84                 Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927503   SRX719192    SRR1595909   ISTH2020          LASV368_ERCC112                Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927484   SRX718789    SRR1594651   ISTH0230          LASV435_ERCC96                 Human      RNase H                Figure 2                                        **+**
  LASV    PRJNA254017   SAMN02927592   SRX719159    SRR1595835   LM032.dep         LM032_Depleted                 Mastomys   RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN02927592   SRX718836    SRR1594698   LM032.std         LM032_Standard                 Mastomys   RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099734   SRX733666    SRR1613388   NHP_DK9W-AG.dep   728_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099735   SRX733667    SRR1613389   NHP_DK9W-AG.std   728_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099736   SRX733668    SRR1613390   NHP_DK9W-AL.dep   729_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099737   SRX733669    SRR1613391   NHP_DK9W-AL.std   729_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099738   SRX733670    SRR1613392   NHP_DK9W-B.dep    734_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099739   SRX733671    SRR1613393   NHP_DK9W-B.std    734_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099740   SRX733672    SRR1613394   NHP_DK9W-K.dep    733_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099741   SRX733673    SRR1613395   NHP_DK9W-K.std    733_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099742   SRX733674    SRR1613396   NHP_DK9W-L.dep    731_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099743   SRX733675    SRR1613397   NHP_DK9W-L.std    731_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099744   SRX733676    SRR1613398   NHP_DK9W-S.dep    732_Depleted                   Macaque    RNase H                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN03099745   SRX733677    SRR1613399   NHP_DK9W-S.std    732_Standard                   Macaque    RNA seq                Figure 3                                        **+**
  LASV    PRJNA254017   SAMN02927592   SRX719168    SRR1595853   LM032             LASV68_BLC                     Mastomys   RNA seq                Figure 4, Table 1                               **+**
  LASV    PRJNA254017   SAMN02927476   SRX727329    SRR1606288   G733              LASV_90                        Human      RNA seq                Figure 4, Table 1                               **+**
  LASV    PRJNA254017   SAMN02927592   SRX733690    SRR1613412   LM032             LM032_HS                       Mastomys   Hybrid Selection       Figure 4, Table 1                               **+**
  LASV    PRJNA254017   SAMN02927476   SRX733681    SRR1613403   G733              G733_HS                        Human      Hybrid Selection       Figure 4, Table 1                               **+**
  LASV    PRJNA254017   SAMN02927593   SRX727318    SRR1606277   LM222             LASV_74                        Mastomys   RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN03099732   SRX733664    SRR1613386   Z002              LASV_77                        Mastomys   RNA seq                Table 1                                         **-**
  LASV    PRJNA254017   SAMN03099733   SRX733665    SRR1613387   G090              LASV_79                        Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927477   SRX727310    SRR1606267   G771              LASV94                         Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927399   SRX734464    SRR1614275   G2230             Solexa-100929.tagged_332       Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927483   SRX731079    SRR1610580   ISTH0073          Solexa-106870.tagged_851       Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927500   SRX719163    SRR1595846   ISTH1137          LASV353_BLC                    Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927503   SRX718749    SRR1594606   ISTH2020          LASV368_ERCC03                 Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927504   SRX727274    SRR1606236   ISTH2025          LASV374_ERCC58                 Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927510   SRX718860    SRR1594723   ISTH2050          LASV386_ERCC48                 Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927484   SRX718809    SRR1594671   ISTH0230          LASV435_ERCC53                 Human      RNA seq                Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927593   SRX733692    SRR1613414   LM222             LM222_HS                       Mastomys   Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN03099732   SRX733678    SRR1613400   Z002              Z002_HS                        Mastomys   Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN03099733   SRX733679    SRR1613401   G090              G090_HS                        Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927477   SRX733682    SRR1613404   G771              G771_HS                        Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927399   SRX733680    SRR1613402   G2230             G2230_HS                       Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927483   SRX733683    SRR1613405   ISTH0073          ISTH0073_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927500   SRX733685    SRR1613407   ISTH1137          ISTH1137_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927503   SRX733686    SRR1613408   ISTH2020          ISTH2020_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927504   SRX733687    SRR1613409   ISTH2025          ISTH2025_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927510   SRX733688    SRR1613410   ISTH2050          ISTH2050_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927484   SRX733684    SRR1613406   ISTH0230          ISTH0230_HS                    Human      Hybrid Selection       Table 1                                         **+**
  LASV    PRJNA254017   SAMN02927592   SRX733689    SRR1613411   LM032             LM032_Depleted                 Mastomys   cDNA                   ND, manually added to the original sup file 3   **+**
  LASV    PRJNA254017   SAMN02927592   SRX733691    SRR1613413   LM032             LM032_Standard                 Mastomys   cDNA                   ND, manually added to the original sup file 3   **-**

The results of both analyses are summarized in [Table 4](#pone.0168397.t004){ref-type="table"}. Metavisitor was able to detect Ebola virus in all corresponding sequence datasets ([S16 File](#pone.0168397.s033){ref-type="supplementary-material"}) as well as Lassa virus in 53 out the 55 sequence datasets generated from Lassa virus samples ([S17 File](#pone.0168397.s034){ref-type="supplementary-material"}). Consistently, Matranga *et al* did not report reconstructed Lassa genomic segments from the two remaining datasets, which likely reflects high read duplication levels in the corresponding libraries \[[@pone.0168397.ref031]\]. The reconstructed Lassa virus L segments and Ebola virus genomes are compiled in [S18](#pone.0168397.s035){ref-type="supplementary-material"} and [S19 Files](#pone.0168397.s036){ref-type="supplementary-material"}, respectively. In these sequences, *de novo* assembled segments in uppercases are integrated in the reference guide sequence (lowercase) used for the reconstruction. To note, for viruses with segmented genomes such as Lassa virus, the workflow has to be used separately with appropriate guide sequences for the segment to be reconstructed. As an example, we used this workflow with the filter term "Lassa" for the "Parse blast output and compile hits" tool and the Lassa S segmentNC_004296.1 for guiding the reconstruction ([S20 File](#pone.0168397.s037){ref-type="supplementary-material"}).

At this stage, users can use the genomic fasta sequences for further analyses. For instance, multiple sequence alignments can be performed for phylogenetics or variant analyses, or reads in the original datasets can be realigned to the viral genomes to visualize their coverages, as has been done in Use Cases 1 and 2.

Discussion {#sec022}
==========

Metavisitor performs *de novo* assembly of sequencing reads and detects contigs of viral origin through blast alignments, which then can be clustered to reconstruct a viral genome.

On the one hand, this strategy reduces the rate of false positives since the ability to form contigs that align to known viral sequences is a strong evidence of the presence of a full viral genome in the analyzed datasets. In addition, we advise Metavisitor users to remove sequence reads that align to genomes of hosts, symbionts or parasites, if these are known and available (see [Fig 1](#pone.0168397.g001){ref-type="fig"}). Although this treatment can be skipped (as in Use Case 3--3), it avoids chimeric assemblies of viral and nonviral sequences, while speeding up the assembly of contigs of potential viral origin. It also ensures that sequences of the host genome that have been annotated as Endogenous Viral Elements (EVEs) are not retained for viral contigs assembly. Users should keep in mind that EVEs that have not yet be identified as such may be retained by Metavisitor as potential viral contigs. Should this happen, Webster et al. \[[@pone.0168397.ref013]\] have demonstrated that, when available, mapping of host genome sequencing reads to these contigs allows to discriminate between EVE and virus sequences. As illustrated in Use Case 2--1, when a host is known for having antiviral RNAi pathways, re-mapping small RNA reads and plotting their length distribution can also add support to the infectious origin of candidate viral contigs (21nt read peak, sense and antisense reads aligning along the contig).

On the other hand, Metavisitor workflows may fail to assemble viral contigs when the abundance of viral reads is too low in sequenced samples, or when these reads align to short, scattered regions of viral genomes. However, as illustrated in the Use Case 3--2, it is possible to keep track of these false negatives by implementing a workflow that annotates and counts viral reads before the *de novo* contig assembly steps.

We developed Metavisitor in Galaxy in order to benefit from a well supported framework allowing execution of computational tools and workflows through a user-friendly web interface. In addition, the advanced Galaxy functionalities ensure the highest levels of computational analyses, through rigorous recording of the produced data and metadata and of the used parameters as well as the ability to share, publish and reproduce these analyses (see Metavisitor availability section in Experimental Procedures). Another major benefit is that, as any Galaxy workflow, the Metavisitor workflows may be modified or extended by users. If they are already available in a Galaxy tool shed, integration of new tools in a workflow is straightforward, thanks to the Galaxy workflow editor. Although it requires coding skills, any other freely available software can be adapted to the Galaxy framework and used in a Metavisitor workflow.

Through use cases, we have shown that Metavisitor is adaptable: short or longer reads from small RNAseq, RNAseq or DNAseq can be used as input data with or without adapter clipping; read datasets can be used as is, or compressed using reads-to-sequences or normalization by median procedures \[[@pone.0168397.ref027]\]; a variety of alignment and *de novo* assembly tools can be used, provided that they have been adapted for their execution in the Galaxy framework; finally, although we provide the vir1 nucleotide and protein references to identify sequences of viral origin users are free to upload and work with their own viral references. Thus, Metavisitor provides biologists and clinicians with an accessible framework for detection, reconstruction or discovery of viruses.

Viral sequences reconstructed by Metavisitor can be used in a large range of subsequent analyses, including phylogenetic or genetic drift analyses in contexts of epidemics or virus surveillance in field insect vectors, animal or human populations, or systematic identification of viruses for evaluation of their morbidity. In Use Cases 3--1 to 3--3, we have shown that Metavisitor allows analysis of numerous datasets in batch with consistent tracking of individual samples. Thus, we are confident that Metavisitor is scalable to large epidemiological studies or to clinical diagnosis in hospital environments. For instance, it could be used to analyse RNAseq data from Zika infected patients \[[@pone.0168397.ref032],[@pone.0168397.ref033]\]. Finally, we wish to stress that Metavisitor has the potential for integrating detection or diagnosis of non-viral, microbial components in biological samples. Eukaryotic parasites or symbionts and bacteria are mostly detectable in sequencing datasets from their abundant ribosomal RNAs whose sequences are strongly conserved in the main kingdoms. This raises specific issues for their accurate identification and their taxonomic resolution that are not currently addressed by Metavisitor. However, many tools and databases \[[@pone.0168397.ref034]\] addressing these metagenomics challenges can be adapted, when not already, to the Galaxy framework. For instance, Qiime \[[@pone.0168397.ref035]\] and the SILVA database of ribosomal RNAs \[[@pone.0168397.ref036]\] can be used within Galaxy and could thus be integrated in future Metavisitor workflows aiming at detection and discovery of non virus organisms in deep sequence datasets.

Supporting Information {#sec023}
======================

###### 

Screenshot of the "Retrieve FASTA from NCBI" tool form to retrieve viral nucleotide (A) or protein (B) vir1 sequences. The query string "txid10239\[orgn\] NOT txid131567\[orgn\] NOT phage" retrieves viruses sequences (txid10239) while filtering out cellular organisms sequences (txid131567) and phage sequences.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of an output produced by the "Parse blast output and compile hits" Metavisitor tool.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 1-1.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 1--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 1--3.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for remapping for use cases 1--1, 1--2, 1--3.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 1--4.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 2--1.

(PDF)

###### 

Click here for additional data file.

###### Alignments of small RNA sequence reads to the partially reconstructed Anopheles C virus genome (Use Case 2--1).

Plot shows the abundance of 18--30-nucleotide (nt) small RNA sequence reads matching the genome sequences and histogram shows length distributions of these reads. Positive and negative values correspond to sense and antisense reads, respectively.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for small RNA profiling of contigs.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 2--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for remapping in use cases 2--1 and 2--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Trinity test in Use Case 2--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for SPAdes test in Use Case 2--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 3--1.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 3--2.

(PDF)

###### 

Click here for additional data file.

###### Screenshot of Metavisitor workflow for Use Case 3--3.

(PDF)

###### 

Click here for additional data file.

###### Nora_MV sequence of Nora virus reconstructed by Metavisitor using reads collapsed to unique sequences (Use Case 1--1).

(TXT)

###### 

Click here for additional data file.

###### Nora_raw_reads sequence of Nora virus reconstructed by Metavisitor using raw reads (Use Case 1--2).

(TXT)

###### 

Click here for additional data file.

###### Nora_Median-Norm-reads sequence of Nora virus reconstructed by Metavisitor using normalisation of read abundance by median procedure (Use Case 1--3).

(TXT)

###### 

Click here for additional data file.

###### MAFFT (<http://www.ebi.ac.uk/Tools/msa/mafft/>) Multiple Alignment of the Nora virus genome sequences published (JX220408.1 and NC_007919.3) or generated in Use Cases 1-1 to 1-3 (Nora_MV, Nora_raw_reads and Nora_Median−Norm−reads).

A view of the alignments was produced by MView ([<http://www.ebi.ac.uk/Tools/msa/mview/>]{.ul}). The html file can be visualized by opening it locally with a web browser.

(HTML)

###### 

Click here for additional data file.

###### Output of the "parse blast output and compile hits" tool in Use Case 1--4.

(TXT)

###### 

Click here for additional data file.

###### Output of the "parse blast output and compile hits" tool in Use Case 2--1.

(TXT)

###### 

Click here for additional data file.

###### Output of the "Pick Fasta Sequences" tool in Use Case 2--1.

(TXT)

###### 

Click here for additional data file.

###### Sequences of the 4 contigs generated by the "CAP3 sequence assembly" tool in Use Case 2--1.

(TXT)

###### 

Click here for additional data file.

###### Integration of the 4 assembled contigs ([S8 File](#pone.0168397.s025){ref-type="supplementary-material"}) in the DCV genome scaffold NC_001834.1 by the "blast_to_scaffold" tool.

Lowercase correspond to NC_001834.1 sequences while uppercase correspond to contig sequences.

(TXT)

###### 

Click here for additional data file.

###### siRNA profiling of *de novo* assembled contigs in Use Case 2--1.

Small RNA sequences reads were aligned to the contigs and size distribution and read maps were generated using the "Generate readmap and histograms from alignment files" tool. Plots show the map and abundance of 18--30 nt small RNA reads for indicated contigs and histograms show length distributions of these reads. Positive and negative values correspond to sense and antisense reads, respectively.

(PDF)

###### 

Click here for additional data file.

###### Parsing of blastx alignments with the "blast analysis, by subjects" tool in Use Case 2--2.

(TXT)

###### 

Click here for additional data file.

###### Sequence of the 8919 nt contig in Use Case 2--2.

(TXT)

###### 

Click here for additional data file.

###### MAFFT (<http://www.ebi.ac.uk/Tools/msa/mafft/>) Multiple Alignment in Clustal format of 3 AnCV genomes reconstructed with Oases, Trinity and SPAdes assembly programs.

(TXT)

###### 

Click here for additional data file.

###### Merge of all reports generated by the "Parse blast output and compile hits" tool in Use Case 3--1.

(TXT)

###### 

Click here for additional data file.

###### Merge of all reports generated by the "Parse blast output and compile hits" tool in Use Case 3--2.

These reports are summarized in [Table 3](#pone.0168397.t003){ref-type="table"}.

(TXT)

###### 

Click here for additional data file.

###### Merge of all reports for Ebola virus generated by the "Parse blast output and compile hits" tool in Use Case 3--3.

These reports are summarized in [Table 4](#pone.0168397.t004){ref-type="table"}.

(TXT)

###### 

Click here for additional data file.

###### Merge of all reports for Lassa virus generated by the "Parse blast output and compile hits" tool in Use Case 3--3.

These reports are summarized in [Table 4](#pone.0168397.t004){ref-type="table"}.

(TXT)

###### 

Click here for additional data file.

###### Lassa virus segment L reconstructed sequences in NC_004297.1 scaffold in Use Case 3--3.

(TXT)

###### 

Click here for additional data file.

###### Ebola virus reconstructed sequences in NC_002549.1 scaffold in Use Case 3--3.

(TXT)

###### 

Click here for additional data file.

###### Lassa virus segment S reconstructed sequences in NC_004296.1 scaffold in Use Case 3--3.

(TXT)

###### 

Click here for additional data file.

###### Galaxy tools used in Metavisitor.

(PDF)

###### 

Click here for additional data file.

###### Duration of execution of the Metavisitor workflows.

The times given correspond to execution of the workflows on a 16-core (2GHz) machine with 96 Mo RAM, Galaxy release 16.04.

(PDF)

###### 

Click here for additional data file.

###### Sequence-independent strategy to identify candidate viral contigs (Use Case 2--1).

Set of contigs (Loci) with clear (+), unclear (?) or no siRNA signature were manually selected from [S10 Fig](#pone.0168397.s010){ref-type="supplementary-material"} and tested for significant blastx alignment against the vir1 index and the Non-redundant NCBI protein database (october 201).

(PDF)

###### 

Click here for additional data file.
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